Novartis AGNYSE:NVS
No Matches were found for
- LAST PRICE98.1300
- TODAY'S CHANGE (%)0.2300 (0.2349%)
- Bid / Lots93.3200/ 1
- Ask / Lots99.2800/ 1
- Open / Previous Close97.6600 / 97.9000
- Day Range
- 52 Week Range
- Volume1,195,327
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVS |
|---|---|---|
| 09:32 ET | 16491 | 97.75 |
| 09:33 ET | 2100 | 97.8 |
| 09:35 ET | 7463 | 97.68 |
| 09:37 ET | 2499 | 97.65 |
| 09:39 ET | 5539 | 97.66 |
| 09:42 ET | 3530 | 97.64 |
| 09:44 ET | 2403 | 97.61 |
| 09:46 ET | 3886 | 97.6 |
| 09:48 ET | 4928 | 97.66 |
| 09:50 ET | 1774 | 97.66 |
| 09:51 ET | 4751 | 97.67 |
| 09:53 ET | 4804 | 97.65 |
| 09:55 ET | 5668 | 97.67 |
| 09:57 ET | 2494 | 97.66 |
| 10:00 ET | 2589 | 97.65 |
| 10:02 ET | 3650 | 97.8 |
| 10:04 ET | 3410 | 97.8 |
| 10:06 ET | 3857 | 97.7 |
| 10:08 ET | 3619 | 97.66 |
| 10:09 ET | 4248 | 97.7 |
| 10:11 ET | 6014 | 97.69 |
| 10:13 ET | 4775 | 97.65 |
| 10:15 ET | 3298 | 97.55 |
| 10:18 ET | 1970 | 97.59 |
| 10:20 ET | 3093 | 97.65 |
| 10:22 ET | 6505 | 97.61 |
| 10:24 ET | 5319 | 97.62 |
| 10:26 ET | 2604 | 97.61 |
| 10:27 ET | 2642 | 97.61 |
| 10:29 ET | 5265 | 97.615 |
| 10:31 ET | 5474 | 97.64 |
| 10:33 ET | 1647 | 97.71 |
| 10:36 ET | 1734 | 97.71 |
| 10:38 ET | 2782 | 97.7206 |
| 10:40 ET | 2550 | 97.66 |
| 10:42 ET | 2168 | 97.59 |
| 10:44 ET | 5375 | 97.62 |
| 10:45 ET | 8365 | 97.69 |
| 10:47 ET | 3988 | 97.771 |
| 10:49 ET | 6206 | 97.8 |
| 10:51 ET | 2051 | 97.82 |
| 10:54 ET | 4904 | 97.82 |
| 10:56 ET | 11392 | 97.8 |
| 10:58 ET | 6956 | 97.85 |
| 11:00 ET | 4163 | 97.87 |
| 11:02 ET | 9410 | 97.79 |
| 11:03 ET | 4264 | 97.94 |
| 11:05 ET | 3193 | 97.81 |
| 11:07 ET | 3671 | 97.88 |
| 11:09 ET | 2549 | 97.93 |
| 11:12 ET | 8642 | 98.03 |
| 11:14 ET | 3383 | 97.97 |
| 11:16 ET | 3079 | 98.01 |
| 11:18 ET | 7200 | 98 |
| 11:20 ET | 1472 | 97.97 |
| 11:21 ET | 4116 | 97.9 |
| 11:23 ET | 7562 | 97.91 |
| 11:25 ET | 9264 | 97.92 |
| 11:27 ET | 11277 | 97.9 |
| 11:30 ET | 46677 | 98.03 |
| 11:32 ET | 22947 | 97.94 |
| 11:34 ET | 3043 | 98.08 |
| 11:36 ET | 520 | 97.955 |
| 11:38 ET | 2541 | 97.96 |
| 11:39 ET | 3047 | 97.95 |
| 11:41 ET | 1494 | 97.9301 |
| 11:43 ET | 1527 | 98 |
| 11:45 ET | 5626 | 97.985 |
| 11:48 ET | 1034 | 97.94 |
| 11:50 ET | 1226 | 97.95 |
| 11:52 ET | 3709 | 97.998 |
| 11:54 ET | 3537 | 98.065 |
| 11:56 ET | 2165 | 98.04 |
| 11:57 ET | 2016 | 98.05 |
| 11:59 ET | 7584 | 98.06 |
| 12:01 ET | 900 | 98 |
| 12:03 ET | 516 | 98.02 |
| 12:06 ET | 987 | 97.99 |
| 12:08 ET | 620 | 98.04 |
| 12:10 ET | 2052 | 98.15 |
| 12:12 ET | 1300 | 98.16 |
| 12:14 ET | 875 | 98.1545 |
| 12:15 ET | 1500 | 98.11 |
| 12:17 ET | 1288 | 98.09 |
| 12:19 ET | 1754 | 98.06 |
| 12:21 ET | 1102 | 98.05 |
| 12:24 ET | 6089 | 98.06 |
| 12:26 ET | 1752 | 98.04 |
| 12:28 ET | 3813 | 98.11 |
| 12:30 ET | 860 | 98.13 |
| 12:32 ET | 2092 | 98.13 |
| 12:33 ET | 300 | 98.14 |
| 12:35 ET | 3271 | 98.12 |
| 12:37 ET | 995 | 98.14 |
| 12:39 ET | 2050 | 98.13 |
| 12:42 ET | 650 | 98.12 |
| 12:44 ET | 441 | 98.14 |
| 12:46 ET | 658 | 98.12 |
| 12:48 ET | 832 | 98.16 |
| 12:50 ET | 1007 | 98.16 |
| 12:51 ET | 1008 | 98.155 |
| 12:53 ET | 1804 | 98.17 |
| 12:55 ET | 1670 | 98.18 |
| 12:57 ET | 1370 | 98.159 |
| 01:00 ET | 1846 | 98.16 |
| 01:02 ET | 2351 | 98.15 |
| 01:04 ET | 279 | 98.16 |
| 01:06 ET | 500 | 98.18 |
| 01:08 ET | 5754 | 98.15 |
| 01:09 ET | 400 | 98.11 |
| 01:11 ET | 1178 | 98.1148 |
| 01:13 ET | 1468 | 98.127 |
| 01:15 ET | 500 | 98.16 |
| 01:18 ET | 1500 | 98.168 |
| 01:20 ET | 1105 | 98.2 |
| 01:22 ET | 308 | 98.16 |
| 01:24 ET | 799 | 98.18 |
| 01:26 ET | 2329 | 98.19 |
| 01:27 ET | 1100 | 98.21 |
| 01:29 ET | 201 | 98.215 |
| 01:31 ET | 1745 | 98.175 |
| 01:33 ET | 2772 | 98.22 |
| 01:36 ET | 1210 | 98.26 |
| 01:38 ET | 645 | 98.25 |
| 01:40 ET | 3849 | 98.28 |
| 01:42 ET | 800 | 98.3109 |
| 01:44 ET | 500 | 98.285 |
| 01:45 ET | 300 | 98.32 |
| 01:47 ET | 510 | 98.2997 |
| 01:49 ET | 1485 | 98.319 |
| 01:51 ET | 1503 | 98.275 |
| 01:54 ET | 2745 | 98.25 |
| 01:56 ET | 1622 | 98.23 |
| 01:58 ET | 200 | 98.22 |
| 02:00 ET | 2153 | 98.22 |
| 02:02 ET | 2716 | 98.23 |
| 02:03 ET | 1124 | 98.22 |
| 02:05 ET | 4227 | 98.23 |
| 02:07 ET | 2798 | 98.22 |
| 02:09 ET | 1189 | 98.16 |
| 02:12 ET | 1722 | 98.2 |
| 02:14 ET | 1426 | 98.21 |
| 02:16 ET | 1200 | 98.1901 |
| 02:18 ET | 1717 | 98.17 |
| 02:20 ET | 1206 | 98.16 |
| 02:21 ET | 490 | 98.17 |
| 02:23 ET | 927 | 98.16 |
| 02:25 ET | 1519 | 98.13 |
| 02:27 ET | 1907 | 98.13 |
| 02:30 ET | 1139 | 98.1156 |
| 02:32 ET | 1180 | 98.08 |
| 02:34 ET | 1700 | 98.06 |
| 02:36 ET | 500 | 98.03 |
| 02:38 ET | 2861 | 98.02 |
| 02:39 ET | 8336 | 98.021 |
| 02:41 ET | 751 | 98 |
| 02:43 ET | 1519 | 97.97 |
| 02:45 ET | 1600 | 97.98 |
| 02:48 ET | 550 | 97.95 |
| 02:50 ET | 2469 | 97.9948 |
| 02:52 ET | 1155 | 97.97 |
| 02:54 ET | 500 | 97.96 |
| 02:56 ET | 4105 | 97.98 |
| 02:57 ET | 5000 | 97.96 |
| 02:59 ET | 1111 | 97.99 |
| 03:01 ET | 1576 | 97.97 |
| 03:03 ET | 5415 | 97.96 |
| 03:06 ET | 728 | 97.9649 |
| 03:08 ET | 5491 | 97.99 |
| 03:10 ET | 1911 | 98.01 |
| 03:12 ET | 2517 | 98.049 |
| 03:14 ET | 2800 | 98.04 |
| 03:15 ET | 1588 | 98.0295 |
| 03:17 ET | 3596 | 98.06 |
| 03:19 ET | 2557 | 98.05 |
| 03:21 ET | 3235 | 98.025 |
| 03:24 ET | 1160 | 97.99 |
| 03:26 ET | 3375 | 97.99 |
| 03:28 ET | 2388 | 98.03 |
| 03:30 ET | 3250 | 98.06 |
| 03:32 ET | 3087 | 98.08 |
| 03:33 ET | 3278 | 98.11 |
| 03:35 ET | 3703 | 98.1 |
| 03:37 ET | 2643 | 98.11 |
| 03:39 ET | 3312 | 98.08 |
| 03:42 ET | 3297 | 98.09 |
| 03:44 ET | 4673 | 98.05 |
| 03:46 ET | 3906 | 98.05 |
| 03:48 ET | 7751 | 98.076 |
| 03:50 ET | 8782 | 98.09 |
| 03:51 ET | 16795 | 98.07 |
| 03:53 ET | 5975 | 98.09 |
| 03:55 ET | 9167 | 98.145 |
| 03:57 ET | 15367 | 98.16 |
| 04:00 ET | 13590 | 98.13 |
Nov 28, 2023
DJ FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells, from 2:38PM ET on Tuesday Nov 28, 2023 by Dow Jones
2:38PM ET on Tuesday Nov 28, 2023 by Dow JonesDJ Novartis's Lifted Mid-Term Sales Growth Outlook Came as No Surprise -- Market Talk, from 2:57AM ET on Tuesday Nov 28, 2023 by Dow Jones
2:57AM ET on Tuesday Nov 28, 2023 by Dow Jones*DJ Novartis Upgrades Mid-Term Sales Growth Guidance, from 1:03AM ET on Tuesday Nov 28, 2023 by Dow Jones
1:03AM ET on Tuesday Nov 28, 2023 by Dow Jones
Nov 20, 2023
Novartis showcases significant data updates from Kisqali(R), iptacopan and Scemblix(R) at SABCS and ASH, from 1:15AM ET on Monday Nov 20, 2023 by Dow Jones
1:15AM ET on Monday Nov 20, 2023 by Dow Jones
Nov 13, 2023
DJ Legend Biotech Subsidiary in License Agreement With Novartis, from 8:46AM ET on Monday Nov 13, 2023 by Dow Jones
8:46AM ET on Monday Nov 13, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novartis AG | 221.8B | 27.8x | +0.02% |
AstraZeneca PLC | 199.2B | 34.3x | +2.29% |
Abbvie Inc | 251.4B | 39.3x | +13.33% |
Merck & Co Inc | 259.7B | 57.3x | +25.61% |
Sanofi SA | 118.6B | 11.9x | +17.46% |
Bristol-Myers Squibb Co | 100.5B | 12.7x | +4.53% |
Company Information
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Contact Information
- Headquarters
- Lichtstrasse 35BASEL, Switzerland 4056
- Phone
- ---
- Fax
- ---
Executives
- Independent Non-Executive Chairman of the Board
- Joerg Reinhardt
- Chief Executive Officer, Member of the Executive Committee
- Vasant Narasimhan
- Independent Non-Executive Vice Chairman of the Board
- Simon Moroney
- Chief Financial Officer, Member of the Executive Committee
- Harry Kirsch
- Chief People and Organization Officer, Member of the Executive Committee
- Robert Kowalski
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $221.8B |
|---|---|
Revenue (TTM) | $47.9B |
Shares Outstanding | 2.3B |
Dividend Yield | 3.57% |
Annual Dividend Rate | 3.4987 USD |
Ex-Dividend Date | 03-09-23 |
Pay Date | 03-20-23 |
Beta | 0.56 |
EPS | $3.53 |
Book Value | $28.00 |
P/E Ratio | 27.8x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 19.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
